<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Peck | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/cellslave5/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/cellslave5/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Peck.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">d7799f5828ac630f2caa9e315443f084</guid>
				<title>Peck posted an update: Our report demonstrates that the fellow eye of a patient [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41779/</link>
				<pubDate>Sat, 08 Feb 2025 10:51:28 -0800</pubDate>

									<content:encoded><![CDATA[<p>Our report demonstrates that the fellow eye of a patient with PCG may be at risk of sudden raised IOP resulting in acute hydrops, and early treatment may help to prevent this phenomenon in the fellow eye.</p>
<p> To determine the rates of primary and recurrent glaucoma tube shunt erosions in patients with age-related macular degeneration (AMD)&hellip;<span class="activity-read-more" id="activity-read-more-41779"><a href="http://www.nationalboardinstitute.com/activity/p/41779/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">43a4e89ebd0f4d00c7f63073b532dbe1</guid>
				<title>Peck posted an update: OBJECTIVES The aim of the present study is to report a case [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37392/</link>
				<pubDate>Mon, 03 Feb 2025 10:16:42 -0800</pubDate>

									<content:encoded><![CDATA[<p>OBJECTIVES The aim of the present study is to report a case series of patients with peri-implant medication-related osteonecrosis of the jaw (MRONJ), in particular describing the onset of the condition and surgical treatment outcome. MATERIAL AND METHODS Fifteen consecutive patients with clinical diagnosis of peri-implant MRONJ were&hellip;<span class="activity-read-more" id="activity-read-more-37392"><a href="http://www.nationalboardinstitute.com/activity/p/37392/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d35e7c43b865e73f962a23024a73f7e4</guid>
				<title>Peck posted an update: Prostaglandin E1 is used to maintain ductal patency in [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35716/</link>
				<pubDate>Sat, 01 Feb 2025 10:52:43 -0800</pubDate>

									<content:encoded><![CDATA[<p>Prostaglandin E1 is used to maintain ductal patency in critical congenital heart disease (CHD). The standard starting dose of prostaglandin E1 is 0.05 µg/kg/minute. Lower doses are frequently used, but the efficacy and safety of a low-dose regimen of prostaglandin E1 has not been established.</p>
<p> We investigated neonates with critical CHD who&hellip;<span class="activity-read-more" id="activity-read-more-35716"><a href="http://www.nationalboardinstitute.com/activity/p/35716/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4252c4264933c7fa4ed8393a4fc1579b</guid>
				<title>Peck posted an update: The majority of our patients received corticosteroids, [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33823/</link>
				<pubDate>Thu, 30 Jan 2025 10:48:09 -0800</pubDate>

									<content:encoded><![CDATA[<p>The majority of our patients received corticosteroids, tocilizumab, anticoagulation and prone positioning. While higher mortality rates of &gt;30% have been reported in various studies among hospitalized patients with COVID-19, the majority of hospitalized patients in our cohort survived with a low mortality rate. The majority of our patients&hellip;<span class="activity-read-more" id="activity-read-more-33823"><a href="http://www.nationalboardinstitute.com/activity/p/33823/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">bf40a9b7c505d127002e7d6dc0050996</guid>
				<title>Peck posted an update: PROSPERO) number CRD42020172251.



International [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32296/</link>
				<pubDate>Tue, 28 Jan 2025 18:12:39 -0800</pubDate>

									<content:encoded><![CDATA[<p>PROSPERO) number CRD42020172251.</p>
<p>International Prospective Register for Systematic Reviews (PROSPERO) number CRD42020172251.</p>
<p> Professional support to enhance the early parent-infant relationship in the first months after birth is recommended, but little is known about the effect of universal interventions. The objective was to investigate&hellip;<span class="activity-read-more" id="activity-read-more-32296"><a href="http://www.nationalboardinstitute.com/activity/p/32296/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">400c03fba90fd42f74dd01b1fb4a2f98</guid>
				<title>Peck became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32277/</link>
				<pubDate>Tue, 28 Jan 2025 18:11:07 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>